Tag: Series B

Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment

Financial by 0 comments

Financing supports the approval of U.S. Investigational Device Exemption (IDE), coronary clinical advancement, and expansion into below-the-knee peripheral (BTK) applications. SANTA CLARA, Calif., June 2, 2026 /PRNewswire/ — Advanced NanoTherapies, Inc. (ANT), a clinical-stage medtech…

Continue Reading →

Cathworks Lands $15.8 Million Series B Financing

Coronary/Structural Heart Financial by 0 comments

KFAR SABA, Israel, Oct. 2nd, 2017 /PRNewswire/ — CathWorks Ltd., a leader in the development of non-invasive FFR measurements for guiding coronary interventions, today announced the completion of a $15.8M Series B round of financing, led by Quark Venture and Triventures. The syndicate also included Planven Investments, Pontifax, Corundum Open Innovation, and BioStar Venturesas well as a strategic investor. […]

Continue Reading →